// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A rare cause of lobular panniculitis

Tareg Mudawi - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An unusual presentation of Sweet syndrome

Alaeldin A M Mohamednour - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Bilateral lipoma arborescens as a presenting feature of ankylosing spondylitis

Sameena Khalid - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

A standard case of reactive arthritis? Plot twist!

ANU DESAI - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Glomerulonephritis

ceftriaxone

Association between initial csDMARD strategy and disease activity at 6 months in patients with new onset rheumatoid arthritis

Sarah Wood - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Switching to biosimilar adalimumab: a real world study

Julie Begum - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Adalimumab

The impact of comorbidities on individuals with inflammatory arthritis

Gouri M Koduri - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Use of anakinra for haemophagocytic lymphohistiocytosis in adults

Luke Sammut - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hemophagocytic lymphohistiocytosis

Anakinra

Hyperferritinaemia causes in a UK district general hospital

Tom Fieldman - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal insufficiency

N/A

Long term safety and efficacy of denosumab and zoledronate

Ziad Alkutobi - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Zolendronic acid

An observational study of the predictors of osteoporosis in men

Natalia Kyrtata - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

Teriparatide use in the real world: can we expect cost savings with a switch to generic version?

Tahreem Akram - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Teriparatide

Subcutaneous methotrexate from the get-go: better adherence and tolerability

Catherine Bevington - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methotrexate

A comparison of the effect of written leaflets, online information and real-time Doppler images: a qualitative study in South Asians

Kanta Kumar - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Do early synovitis clinics triage patients with RA affectively?

Natasha Cleaton - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Exeter Biologics Management Plan

Richard Haigh - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

An evaluation of the use of baseline pulmonary function tests in the detection of interstitial lung disease in patients newly diagnosed with rheumatoid arthritis

Ashraful Haque - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Interstitial lung disease

N/A

Understanding which patient-reported outcomes are important to rheumatology patients: findings from ArthritisPower

Tariq Daud - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Musculoskeletal ultrasound of rheumatoid arthritis pregnancy: a single centre experience

Charles Raine - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Seamless transition to a biosimilar

Katherine Wood - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved